Espínola, N. (2024) “Budget impact of upadacitinib in patients with moderate to severe rheumatoid arthritis in Argentina”, Revista Peruana de Medicina Experimental y Salud Pública, 41(2), pp. 129–38. doi:10.17843/rpmesp.2024.412.12934.